163 related articles for article (PubMed ID: 25189995)
1. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
Quach ND; Mock JN; Scholpa NE; Eggert MW; Payré C; Lambeau G; Arnold RD; Cummings BS
Mol Pharm; 2014 Oct; 11(10):3443-51. PubMed ID: 25189995
[TBL] [Abstract][Full Text] [Related]
2. Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.
Mock JN; Costyn LJ; Wilding SL; Arnold RD; Cummings BS
Integr Biol (Camb); 2013 Jan; 5(1):172-82. PubMed ID: 22890797
[TBL] [Abstract][Full Text] [Related]
3. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.
Sukocheva O; Menschikowski M; Hagelgans A; Yarla NS; Siegert G; Reddanna P; Bishayee A
Semin Cancer Biol; 2019 Jun; 56():116-127. PubMed ID: 29104026
[TBL] [Abstract][Full Text] [Related]
4. Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A
Najahi-Missaoui W; Quach ND; Somanath PR; Cummings BS
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321758
[TBL] [Abstract][Full Text] [Related]
5. Identification of Epithelial Phospholipase A
Nolin JD; Ogden HL; Lai Y; Altemeier WA; Frevert CW; Bollinger JG; Naika GS; Kicic A; Stick SM; Lambeau G; Henderson WR; Gelb MH; Hallstrand TS
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):825-836. PubMed ID: 27448109
[TBL] [Abstract][Full Text] [Related]
6. CENPA knockdown restrains cell progression and tumor growth in breast cancer by reducing PLA2R1 promoter methylation and modulating PLA2R1/HHEX axis.
Wu G; Fan Z; Li X
Cell Mol Life Sci; 2024 Jan; 81(1):27. PubMed ID: 38212546
[TBL] [Abstract][Full Text] [Related]
7. Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth
Friedemann M; Nacke B; Hagelgans A; Jandeck C; Bechmann N; Ullrich M; Belter B; Neuber C; Sukocheva O; Pietzsch J; Menschikowski M
Oncotarget; 2018 Nov; 9(89):35983-35996. PubMed ID: 30542512
[TBL] [Abstract][Full Text] [Related]
8. PLA2R1: expression and function in cancer.
Bernard D; Vindrieux D
Biochim Biophys Acta; 2014 Aug; 1846(1):40-4. PubMed ID: 24667060
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
[TBL] [Abstract][Full Text] [Related]
10. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
[TBL] [Abstract][Full Text] [Related]
11. PLA2R1 kills cancer cells by inducing mitochondrial stress.
Augert A; Vindrieux D; Girard CA; Le Calvé B; Gras B; Ferrand M; Bouchet BP; Puisieux A; de Launoit Y; Simonnet H; Lambeau G; Bernard D
Free Radic Biol Med; 2013 Dec; 65():969-977. PubMed ID: 23994771
[TBL] [Abstract][Full Text] [Related]
12. [New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy].
Girard CA; Seitz-Polski B; Dolla G; Augert A; Vindrieux D; Bernard D; Lambeau G
Med Sci (Paris); 2014 May; 30(5):519-25. PubMed ID: 24939538
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells.
Menschikowski M; Platzbecker U; Hagelgans A; Vogel M; Thiede C; Schönefeldt C; Lehnert R; Eisenhofer G; Siegert G
BMC Cancer; 2012 Dec; 12():576. PubMed ID: 23217014
[TBL] [Abstract][Full Text] [Related]
14. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids.
Jensen SS; Andresen TL; Davidsen J; Høyrup P; Shnyder SD; Bibby MC; Gill JH; Jørgensen K
Mol Cancer Ther; 2004 Nov; 3(11):1451-8. PubMed ID: 15542784
[TBL] [Abstract][Full Text] [Related]
15. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
[TBL] [Abstract][Full Text] [Related]
16. PLA2R1 promotes DNA damage and inhibits spontaneous tumor formation during aging.
Huna A; Griveau A; Vindrieux D; Jaber S; Flaman JM; Goehrig D; Azzi L; Médard JJ; Djebali S; Hernandez-Vargas H; Dante R; Payen L; Marvel J; Bertolino P; Aubert S; Dubus P; Bernard D
Cell Death Dis; 2021 Feb; 12(2):190. PubMed ID: 33594040
[TBL] [Abstract][Full Text] [Related]
17. PLA2R1 mediates tumor suppression by activating JAK2.
Vindrieux D; Augert A; Girard CA; Gitenay D; Lallet-Daher H; Wiel C; Le Calvé B; Gras B; Ferrand M; Verbeke S; de Launoit Y; Leroy X; Puisieux A; Aubert S; Perrais M; Gelb M; Simonnet H; Lambeau G; Bernard D
Cancer Res; 2013 Oct; 73(20):6334-45. PubMed ID: 24008317
[TBL] [Abstract][Full Text] [Related]
18. Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation.
Lateb M; Ouahmi H; Payré C; Brglez V; Zorzi K; Dolla G; Zaidan M; Boyer-Suavet S; Knebelmann B; Crépin T; Courivaud C; Jourde-Chiche N; Esnault V; Lambeau G; Seitz-Polski B
J Immunol Res; 2019; 2019():1324804. PubMed ID: 32083137
[TBL] [Abstract][Full Text] [Related]
19. Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A
Verma A; Najahi-Missaoui W; Cummings BS; Somanath PR
Oncol Lett; 2020 Nov; 20(5):179. PubMed ID: 32934746
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the Phospholipase A2 Receptor 1 Promoter Region in Childhood B Cell Acute Lymphoblastic Leukaemia.
Friedemann M; Gutewort K; Thiem D; Nacke B; Jandeck C; Lange BS; Sukocheva O; Suttorp M; Menschikowski M
Sci Rep; 2020 Jun; 10(1):9058. PubMed ID: 32493972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
